{"name":"Aura Biosciences","slug":"aura-biosciences","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxQSjIwZzBraTIwbVZfdU5LVXpHVE5VOExXZGVKSXk4aEY0eG5CVWRSMk5oR05qT2wzLXF6LWJOMnJjZVd0TmRQS3hLTU5YUXB1ek1PVTRBTjBTbWNOQ2E5SzlrTnJtYndPMWM5X1VqOXVmZjB2Y0NIRndPTlQxN1NGN3RLWW1RbV96NUlpS21JX1p6SVVhVXdYVzNYT05DZkU1WHpfaTZEVXJoZktrdWdvalMtVE9qWWxNRDNmUk5aWW1OR0c0enFyS3Y1cjlrUXQ1UG1lZS1wMUpJcFdrby10NVV1dk1wU0V5SEI4c2hQZ3AyQkZEdFpleWJGbVcxWDJYNURMWF9GYnVld2NmXzVfY3pJRHBWZkQ0QVlvN0tuTUpaS3o2OVZ4NUw2WDZUcEh1WE1xWjRqamxGdGVVRUw5ZHJ1dUpidlBjX2IzU3pWekFBdw?oc=5","date":"2026-04-03","type":"trial","source":"Barchart.com","summary":"Non Muscle Invasive Bladder Cancer Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Aura Biosciences, Protara Therapeutics, Vaxiion Therapeutics, Incyte Corp - ","headline":"Non Muscle Invasive Bladder Cancer Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsigh","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxPdWpfRE9DNFBKQTFKRXZxU19sY0tFVnM0NGFfVjRTdkxSSDY5OW9fRzZEMjhMWEE2Vkp2S1dha3RjZU1xTVBhcENZbjE2aHRMTW5iU0tydFRKSUREWHBHRUwzWWxVTGQxRjAza1BJaktUTFNtaUE4allvLU14WU0ybWZSMm9zOXVEVnNWY1Y4ckFRajlUendLZU1LSUZFbTZ6VTRpN2ZNYkUzRHFLdlZWakZ2bjZiX18xRVIzYjNRNld5QmQ2cEdqYWswdHJCVzk3Y0s5YS1DYVZwbVlGb1NvMmpvUjNQamhhaEx1SGlGeXdyRUN0SlhvbkJjYkF2dTd4bTktWFZOalQtRTJiTVVOampJZmVNOEV2eG1MV1pXWEpYRlduMWpZSnFnVTVHSWE2TjV4YVhCN2JIX1Z1dkFTZVpqblA5endudkRoeHRDdTdzZw?oc=5","date":"2026-03-25","type":"pipeline","source":"Barchart.com","summary":"Non Muscle Invasive Bladder Cancer Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | CG Oncology, Janssen, Tyra Biosciences, UroGen Pharma - B","headline":"Non Muscle Invasive Bladder Cancer Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQNUZ5YlVPT2hRcTFxWEhOMjZ3WUczaU1KTHNZU3pBUlRJNXU4T3FfdEE3SE00c2JYNWpvODVFY1VXUi1NRTNpLTZCdUVNMVB0VXhQcjZFQTZMck1CTXpGdmhjdGN2RTBiMFdsTlBiS3hwSWctZE05bERJWXJqR1pBZHczeHRQdmUyRUpWQWlCNC1zZ3J0SlF5US0yaE9BWXc?oc=5","date":"2026-01-26","type":"pipeline","source":"BioXconomy","summary":"Biotech companies name new finance executives - BioXconomy","headline":"Biotech companies name new finance executives","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNcEJ4dmVQdlRZVEs1UE5zbkdBaUZ2TW14X0dFajlXVDBNeXVPa3VTV3o5QjJtcF83d3cwWXZIQ3dtTjVqeFlsMWdHUHp0N0lpd25YQkgwVFl5WlV0d1RrZldYRDBPdHg1OERHVXlHWDhUTXp5aVBVbXlNN0JNN3NvaFQteUs1TnlBN0ZwZ0VncWVkZw?oc=5","date":"2026-01-22","type":"pipeline","source":"pharmaphorum","summary":"Changing Faces: Board appointments, November and December 2025 - pharmaphorum","headline":"Changing Faces: Board appointments, November and December 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPcW90X20tenBLZTVTa2RKR0drNFNtWnp5RHViZGtGMnpBazYzLW5xWm1aT2MxOWVkRlA2MURyS2s5VmNuV1cxRGE3M3hIXzViMjIweUlvcWx3WVZRSkVZWThXcFdVLU9NWTRwb042NDV5UUNhUXR0dWVhSTZ4S1NiS3d6NkN2T01tSXpyc3R3bmxmdUJWWERlYlJsRUttWEYzbVFmZGNCWTRndGRuNmdsVU80cUc5QlhqNTdpc20zX2gxd2cy?oc=5","date":"2026-01-12","type":"pipeline","source":"businesswire.com","summary":"Obsidian Therapeutics Appoints Julie Feder as Chief Financial Officer - businesswire.com","headline":"Obsidian Therapeutics Appoints Julie Feder as Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPd1hLVnJDZV9wVVczQjhJRnpIeFEyOE4tb1JWUGdRNWllMFdELThrc0RiVzNmSm1JS014Ui10SS1CYzJQT3lhVUZxem5SOXVQWFpacndScXY2V2tveFRRVjEyX3VrY3RQOTN3UDE4VXhKU21rMnhMV2VCRU82TnV5VnFnekswelgwQ2puX1Fhdks3SDdaTmdSRmtqQ2ttMjZSRllmTmNlbU5iQQ?oc=5","date":"2025-12-04","type":"pipeline","source":"PMLiVE","summary":"TRIMTECH Therapeutics appoints Alison Lawton as Chair of the Board - PMLiVE","headline":"TRIMTECH Therapeutics appoints Alison Lawton as Chair of the Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNS24xekhvdXA3ZmVGTjljQTNHRmlyZy1XUnNmeU5qel9pc09vN0FRVW1oR1hhcWRuNmsyMTg0UFFFb1VDX09QTUVYeXBjQ242c3NFd01jeXp3TUhyMUg0ZkFvelRTYWthaWV0RW9KekNBUGJQREpoSG9IamgtbTRYUWV0WHhUNThDb0stV1hDaWg1RUdCYWFYaThFVUxOeHdFNHRpVzZtTVBScnFPVmlJeW51NTE?oc=5","date":"2025-12-04","type":"pipeline","source":"News-Medical","summary":"TRIMTECH Therapeutics appoints Alison Lawton as Chair of the Board - News-Medical","headline":"TRIMTECH Therapeutics appoints Alison Lawton as Chair of the Board - News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQOTMwcTBTVjc2MTloUDdCTzZNMlI2TWktWDNoazQ5Z0lGZnEzR3ZhZkY5R2NJX3BXZGlkc3VPcy1hVEtkdWlycGZwalN3MjQzWnY5UGQtMFFYTG9jN1FyNGZoYXppN29sbmpXWENZSzljX21zOGpRQUZua3htanBoZHlETnZkbmFFUVpJLXVaeWdZWWw3ZEJZ?oc=5","date":"2025-12-04","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Painting a Bull’s-eye on Undruggable Cancer Targets - Genetic Engineering and Biotechnology News","headline":"Painting a Bull’s-eye on Undruggable Cancer Targets","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-26","type":"pipeline","source":"simplywall.st","summary":"Is Aura Biosciences (NASDAQ:AURA) In A Good Position To Deliver On Growth Plans? - simplywall.st","headline":"Is Aura Biosciences (NASDAQ:AURA) In A Good Position To Deliver On Growth Plans?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-18","type":"pipeline","source":"simplywall.st","summary":"Have Insiders Sold Aura Biosciences Shares Recently? - simplywall.st","headline":"Have Insiders Sold Aura Biosciences Shares Recently?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQaDBXcnI0Q3V4SHJ3ck5jZXJrdlV3blFDZ3J5OE9nZkxzY1RFdWZjSWVtSGpNcjBORmVRNFlfZXF2TEp1cmI5d3NXOE5yR0JLSUlRbGdyT3Y4bldHamxpX0hSeHFRd2o4YWxpYzc4VGx0clg0dW93WnlfRkhRbVdTTHg1ZXYyWGxHOEdZMXphVFM1Z2dsUzVF?oc=5","date":"2025-07-29","type":"deal","source":"Pharmaceutical Technology","summary":"Re-Vana Therapeutics, Boehringer Ingelheim partner for eye therapies - Pharmaceutical Technology","headline":"Re-Vana Therapeutics, Boehringer Ingelheim partner for eye therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxOZllHX2ZBU1ZZd1BQY25kcFBRWWFiWjQtRlVjNWZQdTZ1Ti1seHBISU1CVWF0OGFIUmoweXFVMWNueW16eXNZbDAySFo5bzd6cmN3WXh6akx5N1cwc1VfeEZ0QVdNTmtMTzE4QmdhelMycTJpRzB2YmZjbkt3SU9CWEwzbWVNdC1nTUlHYXFoclFCY0hSbGlxczBWQmhJMDFGT21WeXRFTmZUSUpSQ2UxdzBIUVlFbFZIcGpFcW0xSklVaEZ6T2xjazVKazFFbTFRMklBMDF4bGxIbG5YbTgyampJclBCNkRRSHhLcG1B?oc=5","date":"2025-05-15","type":"earnings","source":"GlobeNewswire","summary":"Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewswire","headline":"Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}